Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B.

Yu, Lihua; Liu, Xiaoli; Wang, Xinhui; Dang, Zhibo; Jiang, Yuyong; Wang, Xianbo; Yang, Zhiyun

Yu, Lihua; Liu, Xiaoli; Wang, Xinhui; Dang, Zhibo; Jiang, Yuyong; Wang, Xianbo; Yang, Zhiyun.

Afiliación

Yu L; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China.
Liu X; First Clinical Medical College, Beijing University of Chinese Medicine, Chaoyang District, Beijing 100029, P.R. China.
Wang X; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China.
Dang Z; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China.
Jiang Y; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China.
Wang X; First Clinical Medical College, Beijing University of Chinese Medicine, Chaoyang District, Beijing 100029, P.R. China.
Yang Z; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China.

J Cancer ; 10(18): 4237-4244, 2019.

Article en En | MEDLINE | ID: mdl-31413742

Palabras clave

Barcelona Clinic Liver Cancer classification; Gender; HBV-related Hepatocellular carcinoma; Risk factors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude Idioma: En Revista: J Cancer Año: 2019 Tipo del documento: Article Pais de publicación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google